GE HealthCare in talks over $1bn deal for maker of cancer scan chemicals
AI Summary
GE HealthCare is reportedly negotiating a $1 billion acquisition of Sofie Biosciences, a company specializing in chemicals used in cancer scans. This move marks a significant step for GE HealthCare, which recently split from General Electric, as it seeks to bolster its medical imaging capabilities. The acquisition could enhance GE HealthCare's market position in oncology imaging and reflects its strategic focus on expanding its product portfolio in critical areas of healthcare.
Original Source
Read the full article at Ft →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.